Sort
172,184 grants matching “inflammation”
HIV Persistence During Suppressive Antiretroviral Therapy
$993,764Frank Maldarelli · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
H. pylori-Induced Inflammation and gastric cancer
$993,628Richard M Peek · Vanderbilt University Medical Center · P01 · FY2016 · CA
Midwest Developmental Center for AIDS Research (D-CFAR)
$993,578Elvin H. Geng · Washington University · P30 · FY2025 · AI
Harnessing engineered T regulatory cells to promote beta cell health in T1D
$993,436Jane Hoyt Buckner · Benaroya Research Inst At Virginia Mason · R01 · FY2022 · DK
Single-cell, multi-omic investigation of epicardial adipose and coronary endothelial dysfunction in type 1 diabetes
$993,436Amit Majithia · University Of California, San Diego · U01 · FY2025 · DK
An Intraperitoneal Insulin Delivery System for Management of Type 1 Diabetes
$993,339Christopher Hanson · Perikinetics Inc · R44 · FY2021 · DK
Anaerobic Manufacturing and Molecular Analytical Process Optimization to Support Clinical Development of Live Biotherapeutic Products
$993,238Ricardo Valladares · Siolta Therapeutics, Inc. · R44 · FY2023 · AI
STING Activators as Therapy for Cancer
$993,220Glen N Barber · Stinginn, Llc · R42 · FY2022 · CA
Chronic Renal Insufficiency Cohort Study II
$993,189Alan S Go · Kaiser Foundation Research Institute · U01 · FY2008 · DK
Aerosolized Vitamin A: Developing a Prevention for Hyperoxic Lung Injury and Bronchopulmonary Dysplasia, with Focus on Neonatal Lung Maturation
$993,128Craig Gelfand · Advent Therapeutics, Inc. · R44 · FY2025 · HL
Tumor Immune Contexture and Breast Cancer Disparities: A Multi-Disciplinary Study in Women of African and European Ancestry
$993,003Christine B. Ambrosone · Roswell Park Cancer Institute Corp · R01 · FY2022 · CA
Antimicrobial and Regenerative Treatment for Oral Mucositis
$992,846Shenda Baker · Synedgen, Inc. · R44 · FY2011 · DE
Inhalation Repurposing of An Approved Drug to Treat Severe Asthma
$992,767John Sullivan · Aeon Respire, Inc. · R44 · FY2023 · HL
AUTOIMMUNITY CENTERS OF EXCELLENCE
$992,726Columbia University Health Sciences · U19 · FY2000 · AI
Neurobiological drivers of mobility resilience: the dopaminergic system
$992,714Caterina Rosano · University Of Pittsburgh At Pittsburgh · U01 · FY2022 · AG
Biomarkers and Pathogenesis of Multiple Sclerosis: From Mouse to Human
$992,711Dorothy Anne Cross · Washington University · P01 · FY2012 · NS
Mitochondrial dysfunction, oxidative damage and inflammation in claudication
$992,598Iraklis Ilias Pipinos · University Of Nebraska Medical Center · R01 · FY2013 · AG
A Prospective Study of T cell Immune-phenotype and Disease Outcome in Pulmonary Sarcoidosis
$992,527Sonia Leach · National Jewish Health · R01 · FY2021 · HL
Chronic Kidney Disease in Children (CKiD)
$992,525Bradley Alan Warady · Children'S Mercy Hosp (Kansas City, Mo) · U01 · FY2012 · DK
UT Southwestern O'Brien Kidney Research Core Center
$992,500Peter Igarashi · Ut Southwestern Medical Center · P30 · FY2007 · DK
Malaria Pathogenesis and Human Immunity
$992,443Rick Fairhurst · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
SBIR Phase II: High Data Rate Biometric Monitoring
$992,412Ilayda Samilgil · Organic Robotics Corporation · · FY2021 · TIP
PITT-MCRC for Rheumatic and Musculoskeletal Diseases
$992,402C Kent Kwoh · University Of Pittsburgh At Pittsburgh · P60 · FY2011 · AR
An Inhaled Microbiome-Targeted Biotherapeutic for Treatment of COPD
$992,385Teodora Nicola · Alveolus Bio, Inc. · R44 · FY2025 · HL
Biomechanics of Leukocytes and Molecular Imaging Agents
$992,359Michael Brandeau Lawrence · University Of Virginia · R01 · FY2008 · EB